
Legal issues arising from the use of artificial intelligence in drug development
Adriana Tibbitts, Alison Lehner, Frank Rahmani, and Jason Kropp from law firm Sidley Austin talk about the legal risks that AI represents in drug discovery and development. In today’s competitive pharmaceutical industry, drug developers are seeking tools to accelerate development and maximise the commercial potential of their products in a manner that conserves resources and enables them to prioritise their… Read More


